Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 165

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

Open access
Wu, Te-Chia, Xu, Kangling, Martinek, Jan, Young, Robyn R., Banchereau, Romain, George, Joshy, Turner, Jacob, Kim, Kyung In, Zurawski, Sandra, Wang, Xuan, Blankenship, Derek, Brookes, Hannah M., Marches, Florentina, Obermoser, Gerlinde, Lavecchio, Elizabeth, Levin, Maren K., Bae, Sookyoung, Chung, Cheng-Han, Smith, Jennifer L., Cepika, Alma-Martina, Oxley, Kyp L., Snipes, George J., Banchereau, Jacques, Pascual, Virginia, O'Shaughnessy, Joyce, Palucka, A. Karolina · 2018 · Cancer Research

Abstract

Inflammation affects tumor immune surveillance and resistance to therapy. Here, we show that production of IL1β in primary breast cancer tumors is linked with advanced disease and originates from tumor-infiltrating CD11c+ myeloid cells. IL1β production is triggered by cancer cell membrane–derived TGFβ. Neutralizing TGFβ or IL1 receptor prevents breast cancer progression in humanized mouse model. Patients with metastatic HER2− breast cancer display a transcriptional signature of inflammation in the blood leukocytes, which is attenuated after IL1 blockade. When present in primary breast cancer tumors, this signature discriminates patients with poor clinical outcomes in two independent public datasets (TCGA and METABRIC). Significance: IL1β orchestrates tumor-promoting inflammation in breast cancer and can be targeted in patients using an IL1 receptor antagonist. Cancer Res; 78(18); 5243–58. ©2018 AACR. See related commentary by Dinarello, p. 5200

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-18-0413

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 165

Metadata

Authors
Wu, T.-C., Xu, K., Martinek, J., Young, R. R., Banchereau, R., George, J., Turner, J., Kim, K. I., Zurawski, S., Wang, X., Blankenship, D., Brookes, H. M., Marches, F., Obermoser, G., Lavecchio, E., Levin, M. K., Bae, S., Chung, C.-H., Smith, J. L., Cepika, A.-M., Oxley, K. L., Snipes, G. J., Banchereau, J., Pascual, V., O'Shaughnessy, J., & Palucka, A. K.
Venue
Cancer Research
Published
2018-09-14
Volume
78
Issue
18
Pages
5243-5258
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2884462708
Cited by
165
References
10
FWCI
6.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-18-0413
The paper
Wu, T.-C., Xu, K., Martinek, J., Young, R. R., Banchereau, R., George, J., Turner, J., Kim, K. I., Zurawski, S., Wang, X., Blankenship, D., Brookes, H. M., Marches, F., Obermoser, G., Lavecchio, E., Levin, M. K., Bae, S., Chung, C.-H., Smith, J. L., . . . Palucka, A. K. (2018). IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-18-0413

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.